Pharma Stunned to Learn Patents Were Supposed to Expire
The real story: Indonesian ruling against ‘patent evergreening’ by pharma industry sends critical message, patient advocates say STAT · Sep 24, 2026
Our take: Evergreening, for the uninitiated, is the art of changing a drug’s coating, dose or delivery just enough to reset the patent clock. An Indonesian court just said no to it. It remains the only corner of medicine where the old treatment keeps getting newer and the price never gets lower.